Year: 2015

HCC I/II approval to extend

  • 08:59

Immunicum AB (publ) announced today that the Swedish Medical Products Agency and the Ethics Committee has approved that… Read more

GIST-approval

  • 08:31

Immunicum AB (publ) announces that it has received clearance from the Medical Products Agency and the Ethics Committee… Read more

HCC I/II update

  • 12:11

Immunicum AB (publ) today reported an update on the safety and survival data from the ongoing phase I/II… Read more

Patent JPO

  • 10:06

Immunicum AB (publ) reported today that the Japan Patent Office (JPO), has announced that it intends to grant… Read more

RCC I/II update

  • 09:01

Immunicum AB (publ) today announced continued data improvement from the follow-up phase of a phase I/II-trial in eleven… Read more

EPO patent

  • 15:39

Immunicum AB (publ) reported today that the European Patent Office (EPO), has announced that it intends to grant… Read more

Year-end report 14/15

  • 14:11

Immunicum publishes year-end report 14/15. Year-end report 2014-2015

New study in GIST

  • 15:38

Immunicum AB (publ) today announced that it, together with Karolinska Institute and Karolinska University Hospital, has filed an… Read more

Rutgers MTA

  • 13:11

Immunicum AB (publ) has signed a research agreement with Rutgers Cancer Institute of New Jersey, in USA to… Read more

HCC I/II-update

  • 12:52

Immunicum AB (publ) today released an updated report on safety and survival data from the ongoing phase I/II… Read more